Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,17070,67,3.58 [2.29-5.60],2.1912924392087552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,20178,85,1.60 [1.24-2.07],0.0003110993702528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19826,80,1.82 [1.50-2.20],8.39129127005103e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,17683,68,3.14 [1.52-6.49],0.0020359981494086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,19892,84,2.01 [1.54-2.63],3.253798138924668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,20388,88,2.44 [1.61-3.69],2.348568004042728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,17153,67,1.41 [1.12-1.76],0.0029660829652875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",19892,84,2.48 [2.01-3.06],2.843872145367717e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,17070,67,1.81 [1.35-2.44],8.66706256491453e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,20056,84,6.83 [4.79-9.74],2.356211419710065e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,20278,85,1.93 [1.47-2.53],2.0321932576399493e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17070,67,2.05 [1.46-2.89],3.851840137121916e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,20195,84,6.94 [5.02-9.60],1.0152349486150968e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17153,67,6.17 [4.18-9.09],4.0453261379101605e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20478,85,2.43 [1.32-4.49],0.0045713443624755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,20401,87,2.78 [1.88-4.11],3.1833952644939386e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17593,70,5.99 [3.79-9.46],1.6357797888479382e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17153,67,2.55 [1.74-3.74],1.5123801672081387e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,20178,85,2.60 [1.71-3.97],9.121665734993682e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17153,67,2.29 [1.29-4.09],0.0049090650798906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,17688,69,7.44 [5.12-10.81],5.774163065011578e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,17683,70,1.92 [1.22-3.01],0.0044989583765012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,20056,84,4.09 [2.40-6.97],2.151941452094261e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,17300,68,3.25 [1.94-5.47],8.60718578503823e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,17593,70,1.85 [1.28-2.67],0.001152354411554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,20361,84,7.21 [4.16-12.49],1.9756532356903952e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,20447,88,4.39 [3.33-5.79],1.2398228993336404e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,20178,85,2.35 [2.01-2.75],1.859494121702992e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,20278,85,0.34 [0.22-0.53],1.435997147328536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,20442,86,32.92 [15.70-69.01],2.210988329545542e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,20021,84,0.51 [0.37-0.70],3.6740135733418405e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,19658,82,1.98 [1.69-2.33],7.932877527365529e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,19784,80,1.49 [1.12-1.98],0.0054930386923749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,20361,84,3.77 [2.99-4.76],2.743655394662236e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,20478,85,2.62 [1.91-3.60],2.090709946331441e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,17683,68,2.38 [1.30-4.35],0.0047944547089446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,20278,85,1.85 [1.49-2.30],3.009174098943656e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,17228,69,2.71 [1.58-4.64],0.0002968782654231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",20147,85,1.36 [1.15-1.62],0.0004701532395539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,20278,85,0.60 [0.43-0.82],0.0016095341993898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,17188,68,1.63 [1.28-2.09],0.00010095275604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,17153,67,1.56 [1.20-2.03],0.0008360429075079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,20528,88,21.64 [10.06-46.57],3.703643224961567e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",20184,82,1.38 [1.14-1.67],0.0011863204275329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17643,68,2.18 [1.54-3.07],9.658441785009655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,20406,86,24.34 [12.39-47.81],1.949028183260977e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,20178,85,6.00 [2.84-12.69],2.649413523303153e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,19476,84,0.55 [0.37-0.83],0.0037791583811913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,18892,82,0.48 [0.32-0.73],0.0005365313380493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,20261,85,2.62 [1.62-4.24],8.564791649316971e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,20442,86,5.06 [3.49-7.34],1.0367630686055709e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,20001,85,6.56 [3.57-12.08],1.5055422846508635e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,20293,83,1.90 [1.19-3.05],0.007496815361708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,20325,84,5.65 [3.71-8.62],7.862956919831889e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,20442,86,3.76 [2.59-5.47],4.129275540608978e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,19826,83,1.40 [1.15-1.71],0.0007132580794744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,19762,83,2.56 [1.54-4.25],0.0002867969482195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,20401,85,26.75 [14.85-48.16],6.4757362907165585e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,20178,85,1.62 [1.15-2.28],0.0053180136801002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,20278,85,0.51 [0.35-0.76],0.0010153457193601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,17711,69,0.31 [0.17-0.53],3.3543544707866066e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,17711,69,3.34 [2.50-4.47],4.727137298219247e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,17681,69,0.34 [0.23-0.50],8.841557315575815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,16964,69,0.49 [0.33-0.73],0.0005193558155932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,17683,68,0.41 [0.29-0.59],8.867628788845279e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,17683,68,0.49 [0.29-0.82],0.0065281742132087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,20356,85,0.33 [0.23-0.48],1.278738141411804e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,20178,85,4.95 [3.95-6.21],1.7704195752268981e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,20145,84,0.57 [0.39-0.82],0.0029296322042714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,17100,68,1.42 [1.10-1.84],0.006770681152493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,20401,85,2.63 [1.63-4.24],7.285626066288763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,17497,69,1.51 [1.12-2.04],0.007586571357424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,20091,84,7.41 [5.24-10.47],7.521250024651094e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,17683,68,7.27 [3.70-14.28],8.356785255723665e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,19826,80,1.94 [1.42-2.66],3.799883321282032e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,17593,70,2.45 [1.85-3.25],4.558426162609385e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,20401,85,4.06 [2.16-7.63],1.3517084203655934e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,17711,69,1.92 [1.57-2.35],2.021029359642362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17228,69,7.12 [3.92-12.93],1.2000638240413628e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",20361,84,9.46 [5.67-15.77],7.490047962198068e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19826,80,1.98 [1.58-2.48],3.895516365749226e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,19826,80,4.89 [3.36-7.11],1.1486451150947724e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,20294,86,3.61 [2.36-5.51],2.747640798274236e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,20091,84,0.33 [0.23-0.48],2.069620085533641e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,17593,70,1.51 [1.16-1.96],0.0021353617789031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20224,82,2.18 [1.26-3.79],0.0053654189156012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,17300,68,4.91 [2.10-11.46],0.000234702710549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,17300,68,9.88 [5.98-16.34],4.2960835946476884e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17153,67,2.68 [1.82-3.94],6.068517097325938e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,19892,84,9.41 [5.13-17.25],4.4609541838755814e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,20449,85,10.06 [5.38-18.84],5.337502286350593e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,20440,87,2.87 [1.50-5.47],0.00140345615383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,20440,87,1.61 [1.24-2.10],0.0004398252981788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,20361,84,6.82 [4.63-10.04],2.7544435016877845e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,20224,82,2.09 [1.62-2.69],1.0618371983864569e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,17070,67,2.17 [1.37-3.44],0.0010137026669804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,20383,84,5.90 [3.12-11.15],4.7013493299042633e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,20401,85,2.92 [2.16-3.95],3.0926384181134968e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,17676,69,5.48 [1.60-18.71],0.0066599497516316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,17271,69,17.15 [10.25-28.69],2.5936138129974048e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,19849,83,0.54 [0.38-0.76],0.0003750218100351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,20178,85,7.42 [5.24-10.52],2.027208864924208e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,20213,86,0.63 [0.47-0.85],0.0025020297128529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,20494,87,1.58 [1.17-2.13],0.0025788954351582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",19892,84,1.51 [1.26-1.81],7.152366380382446e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,20239,86,0.65 [0.48-0.88],0.0059751092984986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,20442,86,1.86 [1.33-2.61],0.0002858631883378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,20178,85,1.67 [1.15-2.44],0.0074986385558224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,19826,83,1.86 [1.47-2.36],2.168036193853338e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,20058,83,1.63 [1.30-2.03],1.578958738388175e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,17647,71,2.03 [1.49-2.76],6.3544999805762105e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,20206,85,9.16 [4.02-20.85],1.3387365856074037e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,19826,83,0.45 [0.30-0.69],0.0001986158559043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,17431,66,0.53 [0.33-0.86],0.0097606387863786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,20278,85,3.02 [2.10-4.35],2.344430366482278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,20478,85,3.03 [1.81-5.07],2.4573436164975577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,20261,85,2.12 [1.52-2.95],9.761069469521736e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,20528,88,4.14 [2.94-5.83],3.5049744775000283e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,20528,88,2.64 [1.82-3.82],2.7551257282345454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,20478,85,1.51 [1.30-1.75],5.2563756716324456e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,20361,84,2.21 [1.77-2.76],3.006094663049528e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,20478,85,2.99 [2.08-4.31],3.6693130457878927e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,20224,82,1.45 [1.21-1.74],7.021509155741556e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,20224,82,1.79 [1.44-2.22],1.4475112517422488e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,20496,88,4.02 [2.87-5.63],4.98046283876072e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,20442,86,4.04 [2.74-5.94],1.4152556560394632e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,20294,86,4.64 [3.05-7.06],7.703824407824024e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,20091,84,0.44 [0.28-0.68],0.0002885006918233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,20294,86,5.03 [2.82-8.95],4.1049233631647375e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,19912,85,3.67 [2.50-5.37],2.4909833571206927e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,20478,85,3.28 [2.44-4.42],5.085438456958322e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,20401,85,2.60 [1.77-3.82],1.034818108355e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,20360,87,0.37 [0.22-0.60],6.800231648869893e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,20224,82,2.33 [1.34-4.05],0.0027623057102363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,19818,83,2.73 [1.69-4.42],4.008366123021544e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,20478,85,1.79 [1.28-2.51],0.0006294486283346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,20478,85,4.58 [2.53-8.30],5.175140682491811e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,20360,87,4.12 [3.25-5.22],1.240077956845764e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,20091,84,3.97 [2.94-5.37],2.1112606304984781e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,20270,84,11.97 [7.93-18.07],3.086112390421529e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,19826,80,2.79 [2.22-3.52],2.8499082437108626e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,17300,68,6.57 [3.67-11.77],2.2865727927115663e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,20440,87,4.51 [3.14-6.49],4.6307704049862425e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,20374,85,4.37 [3.14-6.08],1.9752310547323097e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,20442,86,2.10 [1.47-3.00],4.879120371605174e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,20294,86,2.15 [1.32-3.49],0.0020625266085536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,20178,85,6.43 [4.85-8.52],1.8996382573880115e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,17153,67,1.93 [1.20-3.09],0.0063771256356428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,20178,85,6.36 [4.03-10.04],2.004516426664991e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,20192,82,2.89 [2.18-3.83],1.244012619677627e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,20267,84,2.28 [1.62-3.19],1.8486971652158708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,20198,85,4.50 [2.98-6.79],8.808734416999686e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,20325,84,5.35 [3.48-8.23],2.400735369855333e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,20406,86,2.12 [1.73-2.61],8.668620504980175e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,19604,81,4.19 [2.88-6.09],5.92969006089512e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,19600,85,6.19 [4.26-9.00],1.4162176043221978e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,17114,67,2.99 [2.22-4.03],5.225506964127e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,20224,82,2.60 [1.89-3.57],3.528262060120853e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,17300,68,2.46 [1.77-3.40],5.8622377998460936e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,20440,87,7.34 [5.00-10.76],1.9184900353035822e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,20478,85,2.91 [2.34-3.64],2.56683176445512e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,17683,70,4.08 [2.82-5.92],1.1871351003865473e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,20224,82,5.10 [3.55-7.34],1.3858141762268397e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,20440,87,1.84 [1.37-2.47],5.592928915630534e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,19536,81,3.58 [2.04-6.28],8.557821168769606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,20294,86,9.65 [5.50-16.94],2.9291329337868863e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,20294,86,5.43 [2.79-10.56],6.216219135014081e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,19826,80,1.51 [1.13-2.01],0.0053163279446577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,20091,84,2.37 [1.81-3.11],4.9006148719647e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,20407,86,1.70 [1.37-2.11],1.590500400807145e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,20278,85,2.17 [1.73-2.72],2.6004971582936803e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,20278,85,4.47 [2.63-7.59],2.9946654873508265e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,20440,87,3.54 [2.38-5.25],3.484840544555594e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,20278,85,3.43 [2.45-4.82],1.0362755200644418e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,20178,85,1.31 [1.10-1.57],0.0029541942913284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,20178,85,2.19 [1.62-2.96],3.0480602616492385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,20297,84,3.36 [1.56-7.25],0.0019934359524186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,20421,85,2.09 [1.39-3.13],0.0003953130183575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17593,70,2.50 [1.66-3.78],1.3131648951254486e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19583,78,1.53 [1.15-2.02],0.002993181181315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17688,69,1.66 [1.20-2.30],0.0021527094895094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19892,84,2.00 [1.45-2.76],2.12489050123427e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,17688,69,0.60 [0.43-0.85],0.0038272786745474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,20497,88,0.65 [0.48-0.89],0.0075005769321494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,20178,85,1.51 [1.12-2.05],0.0072185886157719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,19826,80,2.42 [1.81-3.22],2.0765379114552584e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,17711,69,5.39 [3.11-9.34],1.969587509752082e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,17678,69,0.64 [0.48-0.85],0.0017617508579409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,20294,86,1.75 [1.36-2.25],1.571638533708231e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,20278,85,3.55 [2.37-5.30],6.54464928022599e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,17300,68,0.45 [0.33-0.60],8.156162772408832e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17647,71,2.38 [1.90-2.97],3.653294549010472e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,17598,68,3.00 [2.16-4.15],4.3452154004313086e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,17688,69,1.76 [1.50-2.06],2.8015030810095535e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,20378,86,2.89 [2.01-4.16],8.866165931379601e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,19885,82,2.08 [1.75-2.48],1.894569320541424e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,20325,84,5.66 [3.37-9.51],5.914073115668696e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,17688,69,5.78 [3.92-8.51],8.170074811427131e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,20391,85,5.40 [4.07-7.15],6.044659132371185e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,17688,69,2.06 [1.42-2.98],0.0001237571141838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",20214,84,1.57 [1.17-2.12],0.002745165808657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,20091,84,2.60 [1.52-4.45],0.000516189930735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,17153,67,4.31 [2.12-8.79],5.74954292518553e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,20294,86,4.81 [3.07-7.53],6.682601009618466e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,19892,84,4.10 [2.66-6.31],1.4943351111500446e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,17299,69,0.34 [0.19-0.59],0.0001515687349566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,20224,82,0.32 [0.21-0.49],2.3811057405464945e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,20224,82,1.91 [1.44-2.54],6.909594245328485e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,20221,85,3.78 [2.23-6.42],8.654412103838025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,19826,80,2.60 [1.84-3.68],6.400382055808742e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,20478,85,2.91 [1.96-4.34],1.386411860055068e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,17188,68,2.01 [1.52-2.66],8.492629147700906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,20442,86,9.26 [5.48-15.66],9.914716234451828e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,20478,85,3.65 [2.71-4.92],1.989952091230974e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,17647,71,2.98 [1.67-5.31],0.0002250459427069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,20246,85,0.50 [0.32-0.77],0.001799317367588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,20442,86,2.21 [1.47-3.32],0.0001265887406412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,20294,86,4.89 [2.31-10.33],3.252406413394158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,20224,82,2.53 [1.79-3.56],1.2946222388241374e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,20392,88,18.67 [9.76-35.69],8.546545209566482e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,17688,69,5.14 [2.60-10.15],2.5362697176254266e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,20278,85,5.57 [3.84-8.08],1.275023657381506e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,17300,68,3.17 [2.00-5.03],8.863309807338156e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,20528,88,5.68 [4.22-7.67],4.7664652863863526e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,20270,84,9.54 [6.12-14.86],2.118771845691905e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,17100,68,1.93 [1.30-2.88],0.0011786524706835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",20178,85,1.49 [1.17-1.90],0.0010922425253983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,17683,70,2.94 [1.69-5.12],0.0001358852025928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,20378,86,2.07 [1.60-2.67],2.6711888294065658e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,20331,87,5.01 [3.25-7.71],2.391120778665302e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,20413,86,2.22 [1.36-3.65],0.0015536665762081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,17683,70,4.57 [3.20-6.52],5.1000127343288657e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,17615,68,4.23 [2.46-7.27],1.708899753945066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,20401,85,2.69 [1.91-3.79],1.5657342512290072e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,17300,68,5.52 [3.13-9.75],3.8972417406812705e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,20325,84,2.16 [1.53-3.04],1.0098224868426806e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,19791,80,0.56 [0.44-0.73],9.277632769240232e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,20270,84,8.13 [4.18-15.80],6.522176657322363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,20361,84,13.74 [6.23-30.29],8.202840360458211e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,20091,84,2.12 [1.67-2.69],6.69256261567484e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,20442,86,0.67 [0.50-0.91],0.0087459608703153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,20361,84,3.80 [1.80-7.99],0.0004443043552572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,20528,88,0.38 [0.21-0.66],0.0007803650664216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,20091,84,2.46 [1.72-3.54],1.0668378616139482e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,20361,84,13.25 [7.56-23.23],1.783085658192672e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,17683,68,2.73 [1.74-4.27],1.2206219407669978e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,20091,84,1.63 [1.26-2.09],0.0001595378434917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,17688,69,2.53 [1.29-4.95],0.0066244464029841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,17070,67,1.48 [1.28-1.71],1.1376695666722961e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,20372,85,7.87 [5.23-11.85],4.82475691321313e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,19870,83,1.60 [1.14-2.24],0.0062603478215761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,20303,84,1.32 [1.14-1.52],0.0001271272156986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,20005,84,2.51 [1.75-3.58],4.323930120788151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,17688,69,4.00 [2.36-6.79],2.6764844351044414e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,20265,84,0.56 [0.42-0.74],5.6148363686892415e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,17647,71,0.46 [0.34-0.63],5.972866288992425e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,20334,88,1.80 [1.33-2.43],0.0001410229545839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,19004,78,2.93 [2.27-3.77],1.0481155943119831e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,20278,85,9.84 [5.19-18.65],2.4938090504786174e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,20478,85,4.51 [3.02-6.74],1.8122615613793637e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,15841,70,12.52 [5.75-27.27],1.9864677671197902e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,20349,85,6.97 [4.12-11.80],4.49429102058993e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CWC15,Spliceosome-associated protein CWC15 homolog,17481,70,1.47 [1.11-1.96],0.0079066990216459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,20091,84,3.46 [2.21-5.40],5.05678685227722e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,20224,82,2.42 [1.82-3.23],1.539835237234675e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,20440,87,1.43 [1.25-1.64],2.647456464410414e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,19903,84,1.43 [1.14-1.81],0.0024139710620429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,20501,88,4.98 [2.48-9.97],6.1421253078166495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,20478,85,1.78 [1.19-2.65],0.0050283966080503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,20136,85,1.43 [1.17-1.75],0.0004810230946012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,20361,84,1.85 [1.48-2.31],8.680027353968878e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,20361,84,2.09 [1.38-3.15],0.0004573926909574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,17153,67,1.35 [1.09-1.68],0.0069531573081634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,20208,85,1.46 [1.14-1.87],0.0028905967792583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",20360,87,6.89 [4.29-11.09],1.6863768622180577e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,19892,84,7.79 [4.30-14.14],1.4231602111804029e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20178,85,2.76 [1.98-3.84],1.883649503006855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,20440,87,7.95 [4.50-14.04],9.247422115491585e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,19903,85,1.94 [1.56-2.41],2.256933839331528e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,17009,67,1.59 [1.20-2.11],0.0014311706438779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,19999,85,1.19 [1.05-1.36],0.0084025759601675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,20528,88,2.78 [1.49-5.17],0.0012683353806956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,20062,84,3.20 [2.54-4.02],5.2383900615778424e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,20360,87,10.70 [7.12-16.06],3.2057621982449424e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,17228,69,1.97 [1.55-2.50],2.6753023405502653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,17228,69,0.37 [0.29-0.46],1.285690271542777e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,20225,84,0.46 [0.28-0.76],0.0022882859204001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,17643,68,1.85 [1.43-2.39],3.149438426423672e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,20091,84,1.62 [1.22-2.14],0.0007153416405218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,20224,82,1.97 [1.25-3.10],0.0032738270688366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,19946,85,0.39 [0.20-0.74],0.0044726066863521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,20178,85,3.61 [2.13-6.12],1.9213715240794923e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,20528,88,10.71 [4.62-24.83],3.1895577267744915e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,20367,86,2.03 [1.66-2.49],1.1049634642697928e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,20091,84,2.52 [1.82-3.49],2.658838162913073e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,20087,86,5.45 [4.10-7.25],2.74344916861022e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,17643,68,2.59 [1.37-4.88],0.003364248748555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,20294,86,3.07 [1.69-5.59],0.000231437105661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,20117,84,0.40 [0.27-0.58],2.2651509668368704e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,17560,68,4.03 [3.05-5.33],1.1994839526599177e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,20178,85,2.96 [1.89-4.62],1.9406902127481007e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,20408,86,5.20 [2.99-9.07],5.844151112041964e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17683,70,1.55 [1.20-1.99],0.0007525435026861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",17228,69,1.52 [1.21-1.91],0.000335851490681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,20442,86,5.58 [4.36-7.14],8.599330069304133e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19892,84,2.76 [1.72-4.43],2.66795898119518e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,17228,69,8.43 [4.73-15.03],4.89534155743452e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,17593,70,2.16 [1.64-2.86],5.33206435582113e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,20374,85,10.75 [6.61-17.49],1.159606297869736e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,17643,68,2.02 [1.34-3.05],0.0007938833266316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,20262,85,7.43 [5.33-10.35],2.024818330516872e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,17188,68,1.48 [1.10-1.98],0.0091557638970541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,19826,80,2.01 [1.39-2.89],0.0001955211324761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,17593,70,2.30 [1.37-3.87],0.0015819902562686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFR,Epidermal growth factor receptor,20528,88,0.35 [0.16-0.75],0.0064616445018658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,17683,70,3.95 [2.18-7.15],5.80263143810892e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,19903,84,2.06 [1.50-2.82],7.914935419948088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,16299,68,1.71 [1.18-2.49],0.004968469177997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,20528,88,6.44 [3.02-13.76],1.493747642066524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,20528,88,4.46 [2.50-7.97],4.445614721989186e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,17153,67,1.99 [1.37-2.88],0.0002948339386153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,20335,84,4.14 [2.24-7.64],5.6563476415523365e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,19546,83,3.89 [3.18-4.76],2.291518723273829e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,17300,68,3.67 [1.70-7.91],0.0009345877603882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,20528,88,9.32 [5.89-14.73],1.2572142297624377e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,20058,83,4.60 [3.01-7.03],1.7533183046880125e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,20224,82,1.55 [1.32-1.82],1.0959245239796433e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,20401,86,3.72 [2.66-5.21],1.5265378830515512e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,17153,67,3.58 [2.24-5.71],8.827237533990088e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,20528,88,4.59 [2.85-7.38],3.5448401738841743e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,20294,86,1.70 [1.24-2.34],0.0010425142807457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,20325,84,2.19 [1.56-3.07],6.395619949331523e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,20318,86,3.27 [1.68-6.35],0.0004750108799113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,20356,85,5.39 [2.00-14.49],0.0008503560334685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",20270,84,1.80 [1.53-2.11],6.754891923104863e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",17683,70,3.58 [2.83-4.54],3.678471257979025e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",20528,88,3.51 [2.76-4.48],2.358177777799781e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,20362,87,1.52 [1.17-1.97],0.0015837943813876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,17683,70,2.85 [1.84-4.41],2.97821589562442e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,20178,85,14.68 [7.91-27.26],1.7803766601586256e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,20237,85,13.45 [8.84-20.46],6.48133425920717e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,17593,70,2.91 [2.21-3.83],2.7576728141119072e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,20470,88,2.03 [1.56-2.63],9.905399939914408e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,17688,69,5.94 [3.81-9.28],4.6084955359412206e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,17683,70,1.86 [1.39-2.50],3.7640691118966254e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,20224,82,2.18 [1.46-3.24],0.0001389021166968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,20294,86,1.63 [1.33-2.01],3.1330424482973053e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,20224,85,2.31 [1.50-3.56],0.0001352855796812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,17642,68,3.92 [2.39-6.42],5.742302215422121e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,20228,84,0.52 [0.37-0.74],0.0002558817361884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,20278,85,1.56 [1.12-2.17],0.008065472908515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,20366,83,1.67 [1.26-2.20],0.000365069383045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,19826,80,1.45 [1.22-1.72],2.4815104486061383e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",17070,67,1.77 [1.41-2.23],1.0102758128464036e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,20224,82,1.44 [1.11-1.86],0.0056656952688168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,20408,86,1.64 [1.44-1.88],4.667863960506056e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,20416,86,1.98 [1.67-2.35],8.356833073597295e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,19903,84,4.67 [3.47-6.30],3.910304505298022e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,20360,87,0.36 [0.27-0.49],4.950401287252233e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,17688,69,0.56 [0.41-0.77],0.0002713538241859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,17647,71,0.41 [0.21-0.77],0.0057327257503602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,20360,87,11.72 [6.90-19.89],7.800561649729367e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,17683,68,2.62 [1.99-3.44],5.1679630146274026e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,20091,84,5.97 [3.71-9.59],1.6704380604439494e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,20143,85,2.21 [1.46-3.36],0.0001957640056184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,20478,85,2.90 [1.69-4.95],0.0001010950537034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLH1,Glutamate carboxypeptidase 2,17153,67,1.27 [1.08-1.50],0.0041551237704504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,20275,87,3.19 [2.26-4.52],5.443689764816671e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,20440,87,2.87 [1.58-5.22],0.0005557865842051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,17228,69,6.95 [4.20-11.49],4.0938671251749e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,20230,84,8.38 [5.90-11.90],1.343868742870825e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,20440,87,1.93 [1.31-2.85],0.0009808600912975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,20178,85,5.14 [2.91-9.09],1.718075610380685e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,19903,84,1.80 [1.30-2.50],0.0004052467311812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,20178,85,3.59 [1.41-9.09],0.0071471227706311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,20415,87,3.79 [1.79-8.06],0.0005212472186474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,17070,67,0.46 [0.27-0.80],0.0060043136243353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,17647,71,1.45 [1.28-1.64],4.201249884685136e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,19826,80,2.01 [1.72-2.35],4.767291816756649e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16885,67,1.92 [1.42-2.59],1.92567328782996e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20178,85,4.36 [2.66-7.15],4.837488425358686e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,20528,88,7.09 [5.76-8.74],1.6076496328052476e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,19826,83,2.75 [1.97-3.86],3.6481346768579318e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,19826,80,1.68 [1.26-2.24],0.0003600378396802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,20408,86,15.73 [10.18-24.31],2.521439749196104e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,20178,85,3.69 [1.94-7.02],6.967472336400498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,20036,84,2.80 [1.52-5.15],0.0009691162240142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,20262,85,1.87 [1.36-2.56],9.648879897855652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,20091,84,12.55 [8.82-17.87],7.960080696067441e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,20237,85,1.18 [1.06-1.32],0.0021225479699124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,17643,68,1.63 [1.22-2.17],0.0008577811988062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,17228,69,1.89 [1.39-2.59],6.366159913989727e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,17647,71,4.93 [3.27-7.44],2.9266752308918494e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,19444,82,2.20 [1.28-3.76],0.0041756697560419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,17273,68,2.34 [1.37-3.99],0.0019179461849264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,17153,67,2.11 [1.26-3.53],0.0043992117996998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,17234,68,1.83 [1.48-2.25],2.2041522295596337e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,20440,87,5.38 [3.27-8.86],3.775851868007164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,20178,85,0.83 [0.72-0.95],0.00889651533068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,20442,86,2.72 [1.46-5.06],0.0016415823872625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,20091,84,0.49 [0.34-0.70],8.149730266552587e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,17598,68,2.03 [1.44-2.86],5.582014532308353e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,19718,84,8.59 [4.80-15.35],4.0410151830236214e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,17593,70,2.11 [1.54-2.89],2.868711307381728e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,19892,84,3.60 [2.82-4.58],4.751197423799775e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,17598,68,2.14 [1.68-2.73],6.06963784845876e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,20196,85,6.16 [3.86-9.83],2.6713078242079105e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",20178,85,2.43 [2.00-2.95],3.438182845571607e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,17622,68,0.46 [0.30-0.71],0.0004900808278496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,20184,86,3.76 [2.64-5.35],1.86380593487093e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,20478,85,1.98 [1.21-3.24],0.0062077155254176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",20372,86,0.61 [0.46-0.81],0.0006271698707617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,20442,86,1.46 [1.26-1.68],2.412993565162693e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,20406,86,3.22 [2.67-3.88],1.1073615806002976e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,20294,86,5.18 [3.60-7.44],6.988701447366492e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,20442,86,0.50 [0.35-0.71],9.095081743276848e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,17300,68,4.53 [2.10-9.78],0.0001208112540475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,17683,70,18.88 [8.26-43.16],3.225897654341808e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,20478,85,4.18 [2.72-6.41],5.853530907706184e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,17647,71,1.48 [1.11-1.99],0.0083531662741126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,17606,70,2.13 [1.72-2.62],1.7172225319928565e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",17643,68,2.84 [1.41-5.73],0.0035776244900026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20224,82,5.40 [3.64-8.00],4.59013714808372e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,20442,86,0.42 [0.27-0.64],6.946605663982552e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,20043,85,0.55 [0.36-0.85],0.0063062229067601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,19826,83,1.53 [1.12-2.09],0.0070797314377937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,19989,83,2.21 [1.59-3.07],2.239045311042e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,19826,80,0.30 [0.18-0.52],1.3034619638325033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,17313,69,1.25 [1.07-1.46],0.0039417543094104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17228,69,1.91 [1.27-2.87],0.0018563103874271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,20178,85,2.32 [1.42-3.77],0.0007265057625124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17153,67,4.05 [2.54-6.45],4.052259511743739e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,17598,68,2.76 [1.94-3.91],1.5006920433938414e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,20442,86,6.57 [4.66-9.26],7.482374761608822e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,20161,83,5.29 [3.71-7.54],3.1361696106127307e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,20207,83,10.16 [5.29-19.52],3.4765470572322773e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,20528,88,8.78 [4.32-17.81],1.787587357821756e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,20221,84,3.75 [2.11-6.65],6.621840894810274e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,20528,88,3.58 [1.97-6.49],2.788169918377025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,20528,88,3.06 [1.67-5.61],0.0002843427544893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,20278,85,1.87 [1.25-2.79],0.0021372022351024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,20178,85,4.95 [1.92-12.75],0.0009401494042205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,20442,86,2.93 [1.87-4.59],2.657387221073536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17149,68,3.18 [2.06-4.90],1.648234450887219e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,20361,84,5.76 [3.50-9.50],6.294937377257894e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,20091,84,1.90 [1.36-2.66],0.0001822998189166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,19826,83,1.92 [1.38-2.69],0.0001261405473396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,20224,82,1.94 [1.36-2.75],0.0002247384161545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,20178,85,6.15 [3.90-9.72],6.714099133333714e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,20294,86,7.85 [3.70-16.65],7.771321576130514e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,20505,88,2.25 [1.66-3.06],2.112118449560154e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,20401,85,0.31 [0.22-0.44],3.396279808671136e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,20025,84,3.82 [3.11-4.69],2.734024984018275e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,20213,84,4.57 [3.14-6.64],2.081711469816018e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,20528,88,2.68 [2.13-3.37],2.6049412276350002e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,20278,85,6.91 [4.67-10.23],4.796839174321517e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,17678,69,2.56 [1.80-3.63],1.4157895984260321e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,20178,85,2.36 [1.84-3.04],1.6778734600648053e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,20278,85,4.74 [3.44-6.53],1.883789841889085e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,17683,70,1.53 [1.18-1.98],0.0015083713491722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,19903,84,1.41 [1.19-1.67],8.211822391070926e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,20361,84,3.85 [2.92-5.06],7.138873907326339e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,20178,85,2.14 [1.77-2.59],7.168898681484888e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,20478,85,2.79 [2.02-3.85],3.8001029878780094e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,19903,84,3.07 [2.47-3.82],5.849669957878739e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,17153,67,2.25 [1.54-3.29],2.726447989017884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,20224,82,2.69 [1.55-4.65],0.0004059027698848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,19903,84,4.14 [2.50-6.84],3.0911958156632385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,20478,85,1.71 [1.18-2.46],0.0041641674176846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,19903,84,1.50 [1.26-1.79],5.7299113982572405e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,20207,84,2.57 [1.82-3.63],8.108884289905698e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,20401,85,8.18 [5.42-12.35],1.250671771132129e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,20478,85,7.07 [4.31-11.60],9.217637542523288e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,19748,81,1.82 [1.51-2.19],3.6773329655693096e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,20262,85,27.43 [17.11-43.98],5.362805638923238e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,20239,84,4.94 [1.82-13.40],0.0016931647513232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,20470,88,4.24 [2.84-6.32],1.329256636283137e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,20237,84,2.09 [1.63-2.67],4.497593215090572e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,17598,68,1.58 [1.22-2.05],0.0004931538873613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,20123,87,2.73 [2.22-3.36],1.893517072262059e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,20224,82,1.80 [1.28-2.55],0.0008429094022929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,19903,84,1.88 [1.18-2.99],0.0077004747728776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,17071,67,1.37 [1.10-1.71],0.0045914793705163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,20224,82,3.38 [2.45-4.65],9.039942982119734e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,20224,82,1.70 [1.28-2.25],0.0002648240810162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,20178,85,1.62 [1.38-1.89],1.856657108509251e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,20278,85,10.23 [5.89-17.74],1.3451157632689183e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,17598,68,2.61 [1.97-3.44],1.3804486774607254e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,17300,68,2.32 [1.61-3.37],7.936436735388842e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,20294,86,4.29 [2.53-7.29],6.713942854608146e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,17598,68,1.66 [1.30-2.12],5.08074701707226e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,17593,70,1.67 [1.36-2.05],9.197693377364508e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,17153,67,5.89 [2.56-13.53],2.941106715252381e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,20178,85,1.78 [1.30-2.44],0.0003252690030895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,20224,82,0.33 [0.19-0.55],2.807767770552089e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,20294,86,9.74 [4.97-19.07],3.192241878397253e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,20442,86,0.34 [0.19-0.64],0.0006580187062682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,20162,86,3.34 [1.83-6.10],8.990792217987531e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,19903,84,3.09 [1.65-5.79],0.000446269054165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,20442,86,2.13 [1.50-3.02],2.167030901657852e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,17688,69,3.65 [2.79-4.76],2.055709523586804e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,20401,85,5.16 [3.20-8.30],1.4074477445965148e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,20440,87,5.45 [3.63-8.19],3.3892101204930307e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,17300,68,2.14 [1.45-3.14],0.0001190324242825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,19903,84,1.53 [1.12-2.07],0.0069497944956275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,19903,84,1.69 [1.31-2.18],6.268726782518102e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,20178,85,3.23 [2.02-5.15],9.195744234595762e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,17330,70,1.76 [1.24-2.52],0.0017747761664642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,17070,67,2.43 [1.84-3.20],3.605258805906949e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,17598,68,1.39 [1.08-1.78],0.009375412463822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,20356,85,0.34 [0.18-0.64],0.0007946754280691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,20174,87,2.41 [1.91-3.04],1.525818207537767e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,20442,86,2.47 [2.12-2.88],1.323340934658377e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,16864,67,0.38 [0.20-0.72],0.003139580074852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,20478,85,6.89 [4.70-10.09],4.256222841001497e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,20478,85,2.67 [1.80-3.95],1.0473237638199243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,17647,71,2.38 [1.82-3.12],3.69454658380933e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",20178,85,1.79 [1.51-2.13],2.7548252307270197e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",20184,82,2.50 [2.02-3.10],5.426417177581133e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",17100,68,1.53 [1.35-1.74],2.3608261357911232e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,20178,85,3.45 [2.61-4.56],4.218752299107737e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20270,84,3.91 [3.00-5.09],4.123157173674663e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,20091,84,1.56 [1.29-1.89],4.901780707836432e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,17228,69,4.15 [1.93-8.93],0.0002780379148391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,20449,85,1.66 [1.17-2.35],0.0046058252426757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,20058,83,6.00 [4.54-7.94],4.022163379576918e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,20401,85,1.88 [1.39-2.54],4.686322760464958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,17643,68,1.75 [1.44-2.12],1.6383129712424867e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,19725,82,2.99 [2.12-4.21],3.436341040481589e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,17683,70,2.05 [1.48-2.84],1.672847870944669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,20408,86,1.99 [1.36-2.90],0.0003681144095153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,17643,68,2.06 [1.56-2.72],3.304957154456473e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,20278,85,2.82 [1.86-4.26],1.0304943175356185e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,20340,87,4.35 [2.67-7.10],4.027152694240581e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,17711,69,2.88 [1.88-4.42],1.1163802817802734e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,20270,84,4.22 [3.35-5.33],6.059436790343487e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,20198,85,1.75 [1.28-2.38],0.0004039461883363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,20267,84,8.04 [5.07-12.75],7.462444173591594e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,20295,84,0.61 [0.45-0.82],0.0011779762086089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,20224,82,9.51 [6.27-14.41],2.655587646059028e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20237,85,3.02 [1.69-5.42],0.000198585710416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17683,70,1.90 [1.36-2.66],0.0001787751359798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,20528,88,3.80 [2.04-7.05],2.4428900165227867e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,20447,88,3.20 [1.77-5.77],0.0001105774393231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19903,84,3.70 [2.63-5.21],6.739014218846305e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,17647,71,4.03 [2.44-6.65],4.741290772610453e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,17643,68,3.18 [2.35-4.30],7.499215832563877e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",17228,69,1.43 [1.11-1.84],0.0059670252870471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,19573,83,1.73 [1.27-2.36],0.0004812916804287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,17711,69,2.92 [1.32-6.50],0.0084331959923641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,20372,86,3.19 [1.97-5.15],2.207545377190604e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17093,67,2.70 [1.58-4.59],0.0002554475103782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,20278,85,5.31 [3.47-8.12],1.407144986814562e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,17188,68,1.35 [1.12-1.63],0.0018088088702778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,20178,85,3.06 [2.07-4.52],2.1872887112048626e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,17593,70,2.42 [1.45-4.05],0.0007692452229015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,20224,82,1.90 [1.21-2.97],0.0051104921975041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,20224,82,1.83 [1.26-2.65],0.0015601222396622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,20528,88,6.88 [4.72-10.03],1.1081513645572733e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,19826,80,1.94 [1.56-2.41],3.099461094487255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,20186,84,6.50 [4.32-9.78],2.953968639910152e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,17598,68,1.78 [1.28-2.48],0.0006360515273837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,20012,84,0.60 [0.43-0.84],0.0024759040015598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,20176,84,2.30 [1.66-3.18],5.677421211205151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,20224,82,2.34 [1.36-4.02],0.002016570009197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,20010,82,4.82 [2.98-7.82],1.6889839119635318e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,20091,84,2.51 [1.68-3.74],7.348721402742656e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,19826,80,1.63 [1.20-2.22],0.0019490969417697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17711,69,6.21 [2.13-18.11],0.0008204193227527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,20020,83,1.59 [1.28-1.97],3.0830786896834274e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,17683,70,3.45 [2.11-5.65],8.082371108653432e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,20360,87,5.05 [2.96-8.61],2.806308849064724e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,17647,71,1.76 [1.29-2.41],0.0003528982186174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,20297,84,3.05 [1.64-5.66],0.000412316473575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,20528,88,2.51 [1.91-3.31],5.498911636729369e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,20174,85,2.44 [1.62-3.67],2.0601755804388345e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,20091,84,1.88 [1.40-2.54],3.492866060879898e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,20303,87,2.17 [1.79-2.63],2.6317461344951654e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,20270,84,2.31 [1.42-3.75],0.0007804199278096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,17300,68,0.30 [0.18-0.50],3.14778416378019e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,20270,84,0.39 [0.20-0.74],0.0042240835447318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,17300,68,9.36 [4.81-18.22],4.583151000859918e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,20294,86,4.23 [2.89-6.18],9.215696648950537e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,20224,82,1.31 [1.07-1.61],0.0097685299692556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,19903,84,2.76 [2.02-3.78],2.534476780469876e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLLT1,Protein ENL,17033,67,1.38 [1.09-1.75],0.0073281008716989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,20224,82,1.90 [1.50-2.41],9.527674882049953e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,20178,85,1.79 [1.44-2.22],1.1500795206154877e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,20216,84,1.93 [1.47-2.53],2.0050486452346472e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,20273,86,2.59 [1.96-3.43],2.8779465791895325e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,20294,86,1.86 [1.34-2.59],0.0001989701710545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,19861,84,4.39 [3.02-6.38],9.95866656497506e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MN1,Transcriptional activator MN1,17188,68,1.45 [1.10-1.90],0.0088288587014389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,17683,68,8.20 [4.32-15.57],1.2402449701675995e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,20145,85,1.77 [1.34-2.34],5.713027993938763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,20239,88,1.44 [1.12-1.87],0.0053068231030362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,20440,87,3.88 [2.77-5.43],3.0151306106117364e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,17353,70,1.73 [1.28-2.34],0.000331521678219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,19826,83,4.37 [3.53-5.40],2.694882151953827e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,17033,67,1.60 [1.18-2.18],0.0023973752838392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,19903,84,1.70 [1.39-2.09],3.799522193181081e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,17300,68,0.49 [0.30-0.78],0.0032170225362106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",17683,70,2.27 [1.80-2.85],2.7390639953114665e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",17228,69,1.46 [1.23-1.73],1.2554473167784792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17070,67,1.92 [1.40-2.64],5.342878712637478e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,17228,69,2.07 [1.57-2.74],3.218576989267161e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",17188,68,2.06 [1.68-2.54],1.0535322007326965e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,17070,67,1.66 [1.19-2.32],0.0027182397687331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,17300,68,1.55 [1.23-1.97],0.0002709164423819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,20333,84,1.89 [1.37-2.62],0.0001270573946131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,17114,67,1.52 [1.14-2.03],0.0042735918170159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,20360,87,12.58 [7.64-20.71],2.437162556867999e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,20440,87,0.41 [0.30-0.56],9.352524426308721e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,20192,82,5.35 [3.58-8.00],2.9835408092158923e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17593,70,5.45 [3.60-8.27],1.3684875434700188e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,20442,86,7.40 [4.29-12.77],6.76410340402097e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",19826,80,1.34 [1.14-1.57],0.0002718998103588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,20237,85,8.97 [6.22-12.95],1.0790118333197852e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,20360,87,3.63 [2.68-4.92],1.1167294618872302e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,19765,83,3.23 [2.55-4.09],2.3145073779116493e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,20360,87,0.44 [0.33-0.59],5.963369181149202e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,20478,85,27.32 [16.43-45.41],2.9206644153178408e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19903,84,1.83 [1.44-2.32],8.787289252351036e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,17683,70,2.52 [1.83-3.47],1.437733827082148e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,17647,71,3.82 [2.44-5.98],4.753704679517841e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,16865,68,7.28 [3.60-14.72],3.3751293700863323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOP56,Nucleolar protein 56,17070,67,1.24 [1.06-1.46],0.0084251244939281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",19826,83,2.29 [1.88-2.78],1.8953564156230364e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",19826,83,1.69 [1.41-2.02],1.1736420675069584e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,20528,88,13.28 [4.87-36.20],4.275033170320253e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,17688,69,4.59 [2.06-10.20],0.0001849535696529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,17379,69,2.56 [1.96-3.33],3.561869315906003e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,20278,85,4.05 [3.08-5.31],8.145520962169034e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,19892,84,1.41 [1.24-1.60],8.73551520713519e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,20294,86,1.94 [1.28-2.95],0.0017905970875519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX2,Neuronal pentraxin-2,17688,69,3.20 [1.66-6.16],0.0004997784714927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,20442,86,3.87 [2.74-5.45],1.1852133649157794e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,20278,85,4.86 [3.20-7.37],1.0252978475836277e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,20427,85,10.59 [5.62-19.95],2.7203570496840053e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,17647,71,2.79 [2.17-3.60],2.0135886486546544e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,20224,82,2.93 [2.05-4.18],3.0944623570569078e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,20440,87,0.32 [0.14-0.74],0.0078730345481127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,20278,85,1.61 [1.42-1.81],2.7824527448346382e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,20400,86,2.94 [1.82-4.74],1.02754137695063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,17643,68,3.31 [2.52-4.35],6.8738817680089e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,20294,86,3.73 [2.72-5.11],2.708714509069822e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,16654,67,1.36 [1.10-1.67],0.0041885850789208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,20361,84,0.38 [0.25-0.58],5.085771994369453e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,20178,85,0.55 [0.42-0.73],4.094554065787812e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,20297,84,4.47 [2.59-7.74],8.293193421996363e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,20427,85,10.42 [4.05-26.79],1.1468459598206457e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,20198,87,2.11 [1.31-3.39],0.0020470688292196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19892,84,1.55 [1.15-2.09],0.0042107820167394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,17493,70,3.27 [2.39-4.47],1.4164008131182618e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,17647,71,3.80 [2.91-4.98],1.858800575116972e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,17593,70,2.31 [1.43-3.73],0.0005783180079506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,20415,85,2.91 [1.54-5.51],0.0010425922982041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,20278,85,3.31 [2.49-4.40],1.3040746049313914e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,17593,70,2.08 [1.50-2.88],1.1224196837389868e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,20528,88,2.24 [1.42-3.53],0.0005163121926873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,20405,86,2.61 [1.99-3.42],5.270087594933083e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,20178,85,3.11 [2.30-4.21],2.4053935388284495e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,20278,85,7.64 [4.65-12.55],9.934565068532861e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,17300,68,3.94 [2.40-6.46],5.3147786590334906e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,17070,67,1.58 [1.15-2.16],0.0050026027511332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17153,67,2.95 [2.15-4.06],2.3978368082266507e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,20528,88,4.72 [2.07-10.72],0.0002142502346593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,17300,68,2.31 [1.61-3.33],6.427078976117959e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,20478,85,5.76 [4.05-8.21],2.580389717822853e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,20447,88,2.18 [1.55-3.06],6.361444555953192e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGR,Progesterone receptor,17153,67,1.29 [1.09-1.54],0.0032673350657462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,17593,70,2.24 [1.52-3.29],4.072086049420467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,20091,84,4.58 [3.35-6.26],1.4107183724825285e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,20030,87,2.09 [1.67-2.62],1.1265639558942791e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,20025,86,9.25 [6.38-13.41],9.238063433885672e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,20294,86,7.00 [5.06-9.70],1.023726085603489e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,20294,86,5.34 [3.50-8.17],1.010141446367765e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,20278,85,3.27 [2.21-4.82],2.5498721394441127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,17300,68,0.59 [0.44-0.79],0.0003363086390405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,17683,70,15.06 [6.79-33.37],2.41312526646408e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,17070,67,1.78 [1.34-2.36],6.464141120609045e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,20299,84,0.63 [0.46-0.87],0.0045804270141633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,20091,84,2.19 [1.56-3.08],5.502034178199239e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,20360,87,6.57 [3.69-11.69],1.4751314756459802e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,20499,88,0.53 [0.35-0.80],0.0022924186599062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",20242,86,1.49 [1.19-1.86],0.0005865696025612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,20294,86,0.40 [0.28-0.59],2.604387248007836e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,20141,84,13.66 [8.55-21.83],7.341230953432063e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",17647,71,0.50 [0.34-0.71],0.0001649267504923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,19826,83,1.81 [1.23-2.66],0.0027238928600328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,20278,85,2.19 [1.48-3.24],8.713813674316327e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,17613,71,1.88 [1.28-2.77],0.0014179254956752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,17647,71,2.08 [1.38-3.16],0.0005328953568496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,20426,88,30.92 [19.34-49.44],1.4248077505817571e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,17153,67,2.42 [1.94-3.03],8.334487712462746e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",20178,85,1.94 [1.43-2.63],1.855046283395151e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,17683,68,0.36 [0.24-0.56],3.011092355334124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,19892,84,2.01 [1.19-3.39],0.0088552600100053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,20361,84,0.45 [0.32-0.62],1.780120088753348e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,17153,67,2.06 [1.34-3.18],0.0010869310412482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17643,68,2.08 [1.43-3.03],0.0001226167544618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,20280,87,1.49 [1.25-1.77],5.756022112328449e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,17688,69,20.17 [11.32-35.95],2.1209360801191973e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,20417,88,3.72 [2.75-5.03],1.5202061802800258e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,17363,67,0.54 [0.36-0.82],0.0038666032670279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19903,84,1.67 [1.30-2.16],7.048274261375258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,20442,86,0.55 [0.39-0.77],0.0005427020014683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,19903,84,2.72 [1.85-4.00],3.525369527661543e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,20270,84,4.04 [2.43-6.73],8.103885110810561e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,17688,69,2.94 [1.99-4.33],5.2763844762086864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,19903,84,1.54 [1.13-2.11],0.0067029105877043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,17647,71,1.70 [1.22-2.36],0.0015825466442498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROS1,Vitamin K-dependent protein S,17711,69,0.32 [0.15-0.67],0.0026759430843637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,17166,68,1.63 [1.23-2.16],0.0006538306157015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,17228,69,2.89 [1.71-4.87],7.124939447822154e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,17153,67,2.11 [1.72-2.60],1.1680809787615519e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,20221,85,2.01 [1.26-3.23],0.0035651977151117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,20196,84,7.30 [5.09-10.47],3.841547018828941e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,20442,86,5.71 [2.89-11.27],5.190367939432669e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,17353,70,2.36 [1.45-3.86],0.0005792210296034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,17513,69,2.91 [2.16-3.92],1.971896184257384e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,20091,84,2.04 [1.64-2.53],1.9163532509773987e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,20154,84,5.85 [4.22-8.11],2.4909291459678623e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20224,82,1.77 [1.33-2.37],0.0001023902313504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,19826,83,2.72 [1.82-4.06],1.0048187671936022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTN,Pleiotrophin,19892,84,1.56 [1.12-2.18],0.0092008908104054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,17688,69,3.40 [1.87-6.15],5.51561428356257e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,17593,70,2.05 [1.32-3.20],0.0014074361790989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17593,70,2.49 [1.63-3.81],2.5731292289340007e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,20029,83,3.09 [1.93-4.96],2.7584206596668324e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,19729,82,1.53 [1.15-2.04],0.0039803074619396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,20224,82,2.51 [1.49-4.23],0.000579046275444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,20440,87,4.36 [2.98-6.36],2.4234198639038552e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,17070,67,2.40 [1.99-2.90],4.199162342180455e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,17711,69,0.46 [0.26-0.81],0.0071090284151975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,20328,88,5.08 [3.12-8.27],5.878405176968993e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,17371,68,1.71 [1.31-2.23],8.51419417680274e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,20224,82,0.46 [0.30-0.69],0.0002335371834237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,19826,80,1.67 [1.20-2.32],0.0024363486785357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,20427,85,2.04 [1.55-2.68],3.725593751603618e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,17643,68,2.68 [2.18-3.29],3.5414629865909336e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,20178,85,1.72 [1.37-2.15],2.5548441393783114e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,20178,85,2.72 [2.10-3.52],3.9446118032049996e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,17593,70,1.69 [1.26-2.27],0.0004414066316991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,20175,83,3.23 [2.62-3.98],6.094561784171232e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,20528,88,2.47 [1.99-3.07],2.8636893887142463e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,20528,88,2.24 [1.79-2.79],8.134851744317368e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,20297,84,4.92 [3.74-6.48],6.835492881136845e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,20294,86,4.87 [3.46-6.87],1.6540002310501634e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,20278,85,2.82 [2.42-3.29],1.76489959164487e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20178,85,2.27 [1.39-3.71],0.0009979130824866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,20236,86,2.42 [1.77-3.31],2.6900830511015823e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,20440,87,4.06 [2.30-7.17],1.422398979019747e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,17683,68,4.24 [3.22-5.58],6.7739652884344525e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,17228,69,2.07 [1.62-2.66],8.658975399496762e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,17082,67,4.44 [2.86-6.90],3.420515907078049e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,17554,68,2.36 [1.92-2.89],2.3313992768258126e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,20441,88,7.41 [5.30-10.37],1.2017051919845367e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,20297,84,4.98 [3.11-7.97],2.1577095229948954e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO2,Roundabout homolog 2,20440,87,2.80 [1.36-5.77],0.0051493655358154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,20278,85,3.71 [2.16-6.39],2.059735040865789e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,19826,80,1.51 [1.16-1.97],0.0019948991363025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,20091,84,2.11 [1.30-3.41],0.0025110907129806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,20442,86,4.82 [3.22-7.21],1.9143582703130982e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,20178,85,1.90 [1.26-2.86],0.002196819725437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,20442,86,4.49 [3.38-5.97],4.415938880626822e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,19892,84,1.54 [1.18-2.01],0.0015292142204801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,20178,85,1.55 [1.25-1.94],7.85566396144258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,20440,87,10.05 [6.72-15.03],2.43996212193269e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,19826,83,1.38 [1.09-1.74],0.0072206636631331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,19717,83,4.65 [3.64-5.94],6.352777167278186e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,20528,88,2.60 [1.72-3.94],6.024708615500328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,20440,87,8.45 [5.43-13.14],2.6560962138657747e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,20330,86,9.77 [6.10-15.66],2.690714373257197e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,20280,84,1.87 [1.29-2.71],0.0010222494693987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,19903,84,3.40 [2.52-4.59],1.0596892740498164e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,20372,86,1.78 [1.22-2.58],0.0026830112817929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,17228,69,2.78 [1.76-4.41],1.278979511414731e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,17683,70,2.89 [1.81-4.61],8.228506354083735e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,20278,85,3.27 [2.28-4.70],1.17049851883517e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,20278,85,0.48 [0.33-0.70],0.0001501172731921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,20528,88,2.40 [1.64-3.50],5.55823847267436e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,20278,85,6.07 [3.14-11.73],8.29543195575231e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,17153,67,2.74 [1.75-4.28],1.0004467511207376e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,20470,88,3.45 [2.60-4.56],5.5858650002313456e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,17620,71,3.45 [2.53-4.72],6.010248185144612e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,17352,69,8.51 [2.13-33.99],0.0024435343996179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,20074,84,1.78 [1.43-2.20],1.9261755252965185e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,17681,69,2.96 [1.33-6.56],0.0076478829419739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,17432,69,5.10 [2.64-9.86],1.3034538642399424e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,20360,87,2.90 [1.58-5.34],0.0005916330621808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,20178,85,3.18 [1.84-5.50],3.420296062057286e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,20027,84,2.21 [1.63-3.01],3.861295162452403e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,17300,68,2.15 [1.21-3.81],0.008620849179928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,17100,68,1.42 [1.11-1.81],0.0047470820398498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,17688,69,3.03 [2.38-3.87],5.754184771997573e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,20325,87,1.74 [1.16-2.61],0.0070120545824589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,20361,84,3.98 [2.92-5.42],1.877178827873361e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,20224,82,2.80 [2.24-3.50],1.3602302962811891e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,20294,86,1.42 [1.14-1.77],0.0016056351856375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,20442,86,3.61 [2.52-5.16],2.1579106046204507e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,20278,85,4.01 [2.26-7.13],2.162355247069163e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,17228,69,3.10 [1.94-4.93],2.038320038852434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,20344,87,2.67 [1.75-4.09],5.873453376724819e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,20244,84,3.47 [2.49-4.84],1.8266605469273477e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,19903,84,1.86 [1.34-2.58],0.0002113853119092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,19903,84,2.49 [1.94-3.19],4.967273076432639e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,19826,80,2.73 [2.01-3.71],1.393718803616508e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,20224,82,2.06 [1.60-2.67],3.244291778507278e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,19826,80,3.50 [2.53-4.83],3.5618381042897636e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,19826,83,1.51 [1.19-1.92],0.0007619069705392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,19826,83,2.03 [1.44-2.87],5.510824039562109e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,20224,82,1.75 [1.39-2.21],2.332333709848017e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,17593,70,1.60 [1.21-2.11],0.0008174054745548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,19826,83,1.45 [1.12-1.88],0.0052163794835723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,20442,86,2.63 [1.68-4.12],2.392464207383388e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,19892,84,2.30 [1.52-3.47],7.158195824534602e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,17593,70,1.66 [1.30-2.12],5.559756690631954e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,17559,68,1.59 [1.13-2.24],0.0082531474159178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,20442,86,3.02 [2.07-4.41],9.427263771489968e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,20361,84,3.56 [2.50-5.07],1.959341346161918e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,20334,86,2.33 [1.65-3.28],1.5223269401894316e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD3,Sphingomyelin phosphodiesterase 3,17153,67,1.58 [1.21-2.06],0.0007463204097339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,17622,71,1.47 [1.19-1.83],0.0004045466651734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,20091,84,2.75 [2.13-3.54],4.304061387525706e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17228,69,2.39 [1.66-3.45],2.7254710637896183e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',17647,71,1.62 [1.22-2.16],0.000996634384676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,17643,68,1.79 [1.40-2.28],3.2589195243983896e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,19826,80,4.71 [3.28-6.77],4.571488779281612e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,17188,68,5.58 [2.46-12.63],3.767924255862199e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,17643,68,1.89 [1.20-3.00],0.0064997666086162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,20294,86,2.96 [2.34-3.74],7.865767832658037e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,20224,82,2.65 [2.20-3.19],4.9704635686535e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,20231,85,3.84 [2.60-5.66],1.1627587576272456e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,20361,84,3.61 [2.29-5.70],3.714474644701695e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,20091,84,0.46 [0.27-0.76],0.0025577827655186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,20297,84,2.36 [1.84-3.02],1.1648120972658303e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,20178,85,9.56 [6.27-14.57],9.675315410783606e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,20505,88,1.87 [1.30-2.71],0.0008539939870293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,17647,71,1.56 [1.13-2.15],0.0073274662899221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,17683,70,3.39 [1.99-5.79],7.308551252592752e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",17153,67,1.87 [1.21-2.89],0.0050997660287842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,20401,85,1.86 [1.19-2.89],0.0063679623959983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",20178,85,2.02 [1.51-2.71],2.212338830085132e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20528,88,2.56 [1.85-3.52],1.0487091503206552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,17688,69,3.31 [1.49-7.37],0.0033316877762105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,20440,87,2.89 [2.14-3.91],5.704334530009443e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,20270,86,6.45 [3.12-13.37],5.173486753567359e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,19826,80,1.48 [1.13-1.95],0.0049149560273968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,20178,85,1.61 [1.29-2.00],2.415046998473232e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,19826,80,1.44 [1.11-1.87],0.0063008880858161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,17153,67,2.30 [1.44-3.69],0.0005276871754255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,20224,82,1.73 [1.21-2.48],0.002584378701611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,20224,82,1.60 [1.26-2.02],0.0001054515619086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,20440,87,1.71 [1.15-2.53],0.0074895791672445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",17643,68,1.60 [1.17-2.19],0.0033807039661418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,20294,86,3.07 [1.86-5.08],1.2611619448620206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,17598,68,2.05 [1.42-2.97],0.000139942143226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,17909,75,2.51 [1.75-3.60],5.732891861578731e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,20178,85,3.63 [2.60-5.07],4.561373353217735e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,20071,84,0.72 [0.60-0.87],0.0005287073247027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,20505,88,4.15 [3.04-5.67],4.550387824107632e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,17683,70,2.52 [1.67-3.79],9.953561601966916e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,20360,87,3.91 [1.72-8.92],0.0011642601657335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,20187,86,2.10 [1.76-2.51],1.8670492732475941e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,20325,84,3.47 [2.68-4.50],6.977584628228199e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,20294,85,2.00 [1.67-2.39],4.736944549143052e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,20306,87,1.48 [1.14-1.92],0.0029211164910447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,20390,85,2.38 [1.58-3.60],3.633349232072309e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,20224,82,3.18 [2.36-4.28],2.1623037311415422e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,20449,85,2.80 [2.06-3.81],4.6414568095665556e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,17153,67,3.93 [2.40-6.45],5.8955992918276425e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,20360,87,4.10 [3.15-5.32],3.951146286964273e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,20528,88,2.67 [1.47-4.85],0.0013306221328001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,17683,68,6.47 [3.49-11.97],2.7891428286619743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,20278,85,4.34 [2.97-6.37],4.7652067491523993e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,20294,86,4.33 [3.33-5.64],1.5577082182025516e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,20319,85,1.91 [1.29-2.83],0.0011974671024475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,20440,87,4.76 [2.98-7.61],7.204677075344215e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17353,70,2.70 [1.91-3.82],1.9209683376269303e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,20105,85,6.08 [4.47-8.28],1.7729121322666453e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,20294,86,1.90 [1.28-2.83],0.0014745479874029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,20207,85,7.07 [3.10-16.14],3.32523064447458e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,17153,67,3.55 [1.88-6.71],9.741456316054957e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,17033,67,1.94 [1.21-3.09],0.0056350059618041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,17620,71,1.91 [1.26-2.89],0.0022071344934029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,20178,85,1.85 [1.50-2.28],8.205421300563818e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,20294,86,1.59 [1.23-2.05],0.0003497325381722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,19865,83,1.88 [1.49-2.36],7.925973937676743e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17593,70,1.73 [1.17-2.57],0.0064744940168989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20091,84,3.70 [2.93-4.66],3.1713424972512003e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20091,84,1.73 [1.53-1.96],5.290919872076077e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20478,85,5.48 [4.13-7.28],7.04679269629803e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20270,84,7.98 [5.01-12.71],2.0885992087533527e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,20360,87,5.70 [4.40-7.38],7.501725685120204e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20297,84,2.27 [1.83-2.82],8.409072835674257e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,20297,84,6.91 [4.81-9.91],1.1342459839805603e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,20442,86,4.16 [3.01-5.75],6.276249376404304e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,20294,86,7.31 [5.40-9.89],4.500343161310112e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20294,86,1.97 [1.66-2.34],7.762301818802328e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,20440,87,4.65 [3.07-7.05],4.1327817824184854e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,20449,85,4.30 [3.22-5.75],4.3596027051541683e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,20091,84,2.19 [1.78-2.68],4.299020336051753e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,20440,87,2.78 [2.05-3.76],4.590907514986285e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20091,84,2.42 [2.04-2.87],1.8053095560550903e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,20478,85,0.34 [0.17-0.71],0.0037014980447101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,20478,85,0.49 [0.31-0.77],0.0019392270330648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,20361,84,6.69 [3.97-11.27],1.008666786600462e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,20501,88,2.95 [1.83-4.77],9.42301604165824e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,17688,69,3.86 [2.58-5.79],6.148466864716875e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,17688,69,2.40 [1.42-4.06],0.0011165842379188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",19892,84,1.42 [1.11-1.81],0.0052210448971537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,20294,86,0.41 [0.21-0.79],0.007819059778418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17683,70,1.50 [1.15-1.97],0.0026996695582486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,17153,67,1.52 [1.17-1.97],0.0018533881759748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,20128,84,1.96 [1.45-2.66],1.400496096656268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,17070,67,1.54 [1.13-2.09],0.0057714343451741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,17643,68,1.66 [1.14-2.41],0.0082440986672643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,17688,69,1.93 [1.37-2.70],0.0001378934453023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,20270,84,1.99 [1.45-2.74],1.927403473461851e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,20442,86,1.60 [1.19-2.15],0.0020037034214323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,17593,70,1.36 [1.08-1.72],0.0088492865329831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,17070,67,1.70 [1.33-2.17],2.3548340837226263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,20440,87,1.73 [1.34-2.23],2.9330704339599545e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,20278,85,2.90 [1.47-5.70],0.0020884227231124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,17070,67,1.31 [1.09-1.56],0.0030794974870345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,20091,84,5.06 [3.73-6.86],1.3843767169072698e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,20478,88,0.34 [0.27-0.44],9.670277635628864e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,17153,67,3.19 [1.81-5.62],5.911508000213692e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,17647,71,2.13 [1.58-2.87],6.070842414579907e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,19892,84,1.58 [1.27-1.95],2.944029084569363e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,19990,84,3.83 [1.94-7.56],0.0001047767563379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,20356,85,7.94 [5.29-11.90],1.3640275948659424e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,20415,85,1.73 [1.27-2.35],0.0004370346686542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,17153,67,4.64 [2.30-9.38],1.8340681916187777e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,20446,85,5.49 [3.44-8.74],7.585078030748868e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,20178,85,2.19 [1.64-2.93],1.0779757137067808e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17070,67,1.89 [1.18-3.03],0.0080265105839039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,17598,68,2.47 [1.94-3.15],1.8103010357405294e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,20270,86,5.58 [4.13-7.53],3.25741009704322e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,19826,83,1.57 [1.18-2.09],0.0020735321881548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,19892,84,1.54 [1.25-1.89],5.057905074381045e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,19826,80,1.98 [1.24-3.17],0.0044544900029868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,20408,86,1.83 [1.17-2.86],0.0078725225949679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,20023,83,3.42 [2.22-5.28],2.8488819971786964e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,20528,88,1.56 [1.21-2.02],0.0006902012142778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,17237,68,1.70 [1.39-2.08],2.008881194324996e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,20413,86,1.62 [1.24-2.12],0.0004178366343243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,19276,82,3.60 [2.81-4.62],5.03578470108146e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",20021,84,0.35 [0.22-0.54],3.677108257416335e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,20442,86,0.34 [0.19-0.62],0.0003463595381721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,19903,84,4.72 [3.38-6.59],6.843439269847347e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,20442,86,1.66 [1.30-2.13],5.773915385495782e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,20441,88,3.77 [2.74-5.20],5.3808705448886445e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,20360,87,0.65 [0.56-0.77],2.1132241841863002e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,17647,71,3.24 [2.32-4.54],6.702862171730304e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,19826,80,1.44 [1.14-1.82],0.0021081745375201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,19892,84,1.54 [1.19-2.00],0.0010743783108392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,17593,70,1.83 [1.38-2.44],3.0598956184074506e-05
